Petera Kiener News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Petera kiener. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Petera Kiener Today - Breaking & Trending Today

Cue Biopharma, Inc. (NASDAQ:CUE) Short Interest Up 36.2% in May

Cue Biopharma, Inc. (NASDAQ:CUE – Get Rating) saw a significant increase in short interest in May. As of May 31st, there was short interest totalling 731,600 shares, an increase of 36.2% from the May 15th total of 537,100 shares. Based on an average trading volume of 243,300 shares, the days-to-cover ratio is currently 3.0 days. […] ....

Stifel Nicolaus , Petera Kiener , Mirabella Financial Services , Cue Biopharma Company Profile , Sigma Planning Corp , Securities Exchange Commission , Dimensional Fund Advisors , Swiss National Bank , Cue Biopharma Inc , Cue Biopharma , Get Rating , Director Peter , Exchange Commission , Fund Advisors , Gate Manager , Planning Corp , National Bank , Cue Biopharma Daily ,

Cue Biopharma (NASDAQ:CUE) Posts Earnings Results, Beats Expectations By $0.04 EPS

Cue Biopharma (NASDAQ:CUE – Get Rating) announced its earnings results on Tuesday. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.04, Zacks reports. The business had revenue of $0.19 million during the quarter, compared to analysts’ expectations of $0.30 million. Cue Biopharma had a negative net margin of […] ....

Petera Kiener , Stifel Nicolaus , Silverarc Capital Management , Millennium Management , Cue Biopharma Company Profile , Cue Biopharma Inc , Renaissance Technologies , Blackrock Inc , Vanguard Group Inc , Cue Biopharma , Get Rating , Biopharma Trading Down , Director Peter , Capital Management , Cue Biopharma Daily , Nasdaq Cue ,

Cue Biopharma, Inc. (NASDAQ:CUE) Short Interest Update

Cue Biopharma, Inc. (NASDAQ:CUE – Get Rating) was the target of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 678,200 shares, a drop of 10.5% from the March 31st total of 757,900 shares. Based on an average trading volume of 141,300 shares, the […] ....

Stifel Nicolaus , Petera Kiener , Silverarc Capital Management , Cue Biopharma Inc , Vanguard Group Inc , Millennium Management , Renaissance Technologies , Voss Capital , Securities Exchange Commission , Cue Biopharma Company Profile , Cue Biopharma , Get Rating , Director Peter , Exchange Commission , Capital Management , Cue Biopharma Daily , Nasdaq Cue ,

Cue Biopharma, Inc. (NASDAQ:CUE) Sees Large Drop in Short Interest

Cue Biopharma, Inc. (NASDAQ:CUE – Get Rating) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 678,200 shares, a decrease of 10.5% from the March 31st total of 757,900 shares. Based on an average daily volume of 141,300 shares, the […] ....

Stifel Nicolaus , Petera Kiener , Bridgefront Capital , Managers Group , Mirabella Financial Services , Connor Clark Lunn Investment Management Ltd , Cue Biopharma Inc , Cue Biopharma , Get Rating , Director Peter , Financial Services , Lunn Investment Management , Montreal Can , Cue Biopharma Daily , Nasdaq Cue ,

Cue Biopharma, Inc. (NASDAQ:CUE) Short Interest Down 10.5% in April

Cue Biopharma, Inc. (NASDAQ:CUE – Get Rating) saw a large drop in short interest in April. As of April 15th, there was short interest totalling 678,200 shares, a drop of 10.5% from the March 31st total of 757,900 shares. Based on an average daily volume of 141,300 shares, the short-interest ratio is currently 4.8 days. […] ....

Stifel Nicolaus , Petera Kiener , Securities Exchange Commission , Millennium Management , Vanguard Group Inc , Voss Capital , Renaissance Technologies , Cue Biopharma Inc , Silverarc Capital Management , Cue Biopharma , Get Rating , Director Peter , Exchange Commission , Capital Management , Cue Biopharma Daily , Nasdaq Cue ,